EX-23.2 2 ex_589826.htm EXHIBIT 23.2 ex_589826.htm

 

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-4 of Cyclo Therapeutics, Inc. of our report dated March 17, 2023, which includes an explanatory paragraph relating to the Cyclo Therapeutics, Inc.’s ability to continue as a going concern, relating to the financial statements of Cyclo Therapeutics, Inc., as of and for the year ended December 31, 2022, appearing in the Joint Proxy Statement/Prospectus, which is part of this Registration Statement.

 

We also consent to the reference to our firm under the heading “Experts” in such Joint Proxy Statement/Prospectus.

 

 

/s/ WithumSmith+Brown, PC

 
   

East Brunswick, New Jersey

 

November 7, 2023